Open AccessThe role of NK cells in oncolytic viral therapy: a focus on hepatocellular carcinoma
Author(s) -
Frazer Warricker,
Salim I. Khakoo,
Matthew D. Blunt
Publication year - 2021
Publication title -
journal of translational genetics and genomics
Language(s) - English
Resource type - Journals
pISSN - 2578-5281
DOI - 10.20517/jtgg.2021.27
Subject(s) - oncolytic virus , hepatocellular carcinoma , immune system , virus , virotherapy , immunology , cancer research , cancer , virology , medicine , biology
Natural killer (NK) cells have a key role in host anti-tumour immune responses via direct killing of tumour cells and promotion of adaptive immune responses. They are therefore attractive targets to promote the anti-tumour efficacy of oncolytic viral therapies. However, NK cells are also potent components of the host anti-viral immune response, and therefore have the potential for detrimental anti-viral responses, limiting the spread and persistence of oncolytic viruses. Oncolytic viruses are currently being investigated for the treatment of hepatocellular carcinoma (HCC), a leading cause of cancer-related death with a high unmet clinical need. In this review, we highlight the role of NK cells in oncolytic virus therapy, their potential for improving treatment options for patients with HCC, and discuss current and potential strategies targeting NK cells in combination with oncolytic viral therapies.